
Bispecific CD19/CD22 CAR T Cells Show Promise in R/R ALL
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000669700.14786.5a
Subject(s) - medicine , cytokine release syndrome , cd22 , blinatumomab , cd19 , oncology , refractory (planetary science) , lymphoma , population , immunotherapy , immunology , chimeric antigen receptor , antigen , cancer , biology , environmental health , astrobiology